(12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione

C25H36FN5O4 — CID 154813824

IUPAC(12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione
SMILESCC(C)N[C@H]1CCCNC(=O)CC2(CCN(C(=O)c3ccc(F)cc3)CC2)NC(=O)CN(C)C1=O
InChIInChI=1S/C25H36FN5O4/c1-17(2)28-20-5-4-12-27-21(32)15-25(29-22(33)16-30(3)24(20)35)10-13-31(14-11-25)23(34)18-6-8-19(26)9-7-18/h6-9,17,20,28H,4-5,10-16H2,1-3H3,(H,27,32)(H,29,33)/t20-/m0/s1
InChIKeyWCRZTUBRFOLDRW-FQEVSTJZSA-N
MW489.59 g/mol
LogP1.04
Rot. Bonds3

About (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione

(12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione (PubChem CID 154813824) has the molecular formula C25H36FN5O4 and a molecular weight of 489.59 g/mol. Its IUPAC name is (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione.

Molecular Properties

Compound Name(12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione
PubChem CID154813824
Molecular FormulaC25H36FN5O4
Molecular Weight489.59 g/mol
Exact Mass489.28
IUPAC Name(12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione
SMILESCC(C)N[C@H]1CCCNC(=O)CC2(CCN(C(=O)c3ccc(F)cc3)CC2)NC(=O)CN(C)C1=O
InChIInChI=1S/C25H36FN5O4/c1-17(2)28-20-5-4-12-27-21(32)15-25(29-22(33)16-30(3)24(20)35)10-13-31(14-11-25)23(34)18-6-8-19(26)9-7-18/h6-9,17,20,28H,4-5,10-16H2,1-3H3,(H,27,32)(H,29,33)/t20-/m0/s1
InChIKeyWCRZTUBRFOLDRW-FQEVSTJZSA-N
XLogP1.04
TPSA110.85 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500489.59
LogP ≤ 51.04
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione?
The IUPAC name of (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione (CID 154813824) is (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione.
What is the SMILES notation for (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione?
The canonical SMILES for (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione is CC(C)N[C@H]1CCCNC(=O)CC2(CCN(C(=O)c3ccc(F)cc3)CC2)NC(=O)CN(C)C1=O.
What is the InChIKey of (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione?
The InChIKey is WCRZTUBRFOLDRW-FQEVSTJZSA-N. The full InChI is InChI=1S/C25H36FN5O4/c1-17(2)28-20-5-4-12-27-21(32)15-25(29-22(33)16-30(3)24(20)35)10-13-31(14-11-25)23(34)18-6-8-19(26)9-7-18/h6-9,17,20,28H,4-5,10-16H2,1-3H3,(H,27,32)(H,29,33)/t20-/m0/s1.
What are the key properties of (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione?
(12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione has a molecular weight of 489.59 g/mol, XLogP of 1.04, 3 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (12S)-3-(4-fluorobenzoyl)-10-methyl-12-(propan-2-ylamino)-3,7,10,16-tetrazaspiro[5.12]octadecane-8,11,17-trione is sourced from PubChem (CID 154813824), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).